News

Science Starlight: Manel Santaeularia In the second episode of our video series, we talk with St. Anna Children’s Cancer Research Institute Postdoc Manel about the motivation behind his exciting research work. He is certain that new technologies and developments are going to make a crucial contribution in driving research forward. Where does he see himself […]

Make an impact – find a cure. Today is Rare Disease Day! Make an impact – find a cure 300 million sounds like a lot but those 300 million people worldwide who are suffering from rare diseases mark only 3.87% of the world’s population. If you are the only one in a group of 2,000,

Rewarding work with a big impact – today is International Childhood Cancer Day! Science Starlight: today’s research efforts for a better future About 300 children and adolescents in Austria develop cancer each year. The young researchers at St. Anna Children’s Cancer Research Institute (St. Anna CCRI) work hard to bring this number closer to Zero

Women in Science Day 2022 Today is Women in Science Day and we would like to present unique women of our research institute. This day is to pay special tribute to the significant role that women and girls play in science! The “International Day of Women and Girls in Science” was established in 2015 by

St. Anna CCRI Facts & Figures on World Cancer Day 2022 Today is World Cancer Day 2022! Check out our video on facts & figures around St. Anna CCRI and pediatric cancer.

Chromosome 21 is the most affected chromosome in childhood acute lymphoblastic leukemia. Many of its numerical and structural abnormalities define diagnostically and clinically important subgroups. In their recent publication, investigators from St. Anna Children’s Cancer Research Institute, St. Anna Children’s Hospital and Labdia Labordiagnostik GmbH have now provided a comprehensive overview of all these types

Top leukemia expert worldwide: Michael Dworzak awarded by independent ranking platform Developing new diagnostic methods for early detection and effective therapy of children and adolescents with leukemia – Univ.-Doz. Dr. Michael Dworzak’s research pursues goals that are vital for pediatric cancer patients. For his tireless efforts, he has now been honored by the international evaluation

The god of sun at the forefront of immunodeficiency-research Scientists link mutations in the transcription factor Helios to a novel disease characterized by immunodeficiency and immune dysregulation. When scientists at St. Anna Children’s Cancer Research Institute (St. Anna CCRI) identified an immune dysregulation caused by a biallelic germline mutation affecting Helios – a transcription factor

Tackling two tasks at once: Alternative method to animal testing for developing therapies against childhood cancer Congratulations to St. Anna Children’s Cancer Research Institute (St. Anna CCRI) scientists Univ. Prof. Dr. Heinrich Kovar and Dr. Branka Radic-Sarikas for winning a grant from the Austrian Science Fund (FWF) under the program “Alternative methods to animal testing”.

ISTT Young Investigator Award 2021! The ISTT (International Society for Transgenic Technologies) Young Investigator Award identifies and recognizes young scientists who advance the science and technologies in the generation and analysis of transgenic animal models for biomedical research and biotechnology applications. Davide Seruggia received the award for his successful complex projects requiring advanced CRISPR technology:

The ONTHETRRAC research team discovered new aspects of tumor heterogeneity and developed tools that are important for accurate diagnosis, prognosis and for overcoming treatment resistance of the nerve tumor neuroblastoma in children. In the December newsletter 2021 its work was therefore honored as a “success story” by the research promotion network European Research Area (ERA-NET).

New FWF-grant approved: Decoding the epigenome and its regulation in neuroblastoma CONGRATS to Irfete Fetahu, PhD, postdoc at St. Anna CCRI on receiving a Stand-Alone Grant from the Austrian Science fund FWF. Together with her PI Sabine-Taschner-Mandl from the Tumor Biology group and colleagues, Irfete has the ambitious goal to decode the epigenome and its

Somatic Sex – the development of malignant diseases reinterpreted How do malignant diseases develop? In his recent publication, Oskar Haas from St. Anna Children’s Cancer Research Institute suggests that the unique chromosome patterns, which define specific tumor types, arise from an accidental fusion of two normal cells – a process that simulates the fertilization of

“Rare diseases are also an emergency!” (27.10.2021)“Rare diseases are also an emergency!” – That was the message from the European Reference Networks (ERNs) for rare diseases to members of the European Parliament at a joint meeting in Strasbourg. Currently, the EU spends a lot of money on combating the pandemics, which is undoubtedly a major

Sabine Taschner-Mandl is elected to the executive board of Europe’s neuroblastoma network SIOPEN Developing new therapies for childhood nerve tumors and identifying more molecular markers for better diagnosis – this is what Sabine Taschner-Mandl strives for in her new role as Executive Committee Board Member of the European Neuroblastoma Research Group SIOPEN. Sabine Taschner-Mandl, PhD,

Childhood cancer is different from cancer in adults. Thus, it needs research specifically tailored to pediatric tumors, which requires dedicated funding. The need for medicines suitable for children, as well as improvements in long-term follow-up care for cancer survivors have been discussed with EU Health Commissioner Stella Kyriakides, M.Ed., and Austrian Health Minister Wolfgang Mückstein,